Gynecologic oncology | 2021
TCGA molecular subgroups of endometrial carcinoma in ovarian endometrioid carcinoma: A quantitative systematic review.
Abstract
BACKGROUND\nOvarian endometrioid carcinoma (OEC) shares morphological and molecular features with endometrial endometrioid carcinoma (EEC). Several studies assessed the four TCGA groups of EEC, i.e. POLE-mutated (POLEmut), mismatch repair-deficient (MMRd), no specific molecular profile (NSMP) and p53-abnormal (p53abn), in OEC; however, it is unclear whether the TCGA groups have the same distribution and clinicopathological features between OEC and EEC.\n\n\nOBJECTIVE\nTo assess the distribution and clinicopathological features of the TCGA groups in OEC.\n\n\nMETHODS\nA systematic review and meta-analysis was carried out by searching 7 electronic databases from January 2013 to April 2021 for studies assessing the TCGA classification in OEC. Prevalence of each TCGA group in OEC and of FIGO grade 3 and stage>I was pooled using a random-effect model. Prevalence of TCGA groups was compared between OEC and EEC, extracting EEC data from a previous meta-analysis. Kaplan-Meier and Cox regression survival analyses were performed for progression-free survival (PFS). A significant p-value<0.05 was adopted.\n\n\nRESULTS\nFour studies with 785 patients were included. The frequency of the TCGA groups in OEC vs EEC was: POLEmut\xa0=\xa05% vs 7.6% (p\xa0=\xa00.594); MMRd\xa0=\xa014.6% vs 29.2% (p\xa0<\xa00.001); p53abn\xa0=\xa014% vs 7.8% (p\xa0=\xa00.097); NSMP\xa0=\xa066.4% vs 55.4% (p\xa0=\xa00.002). The pooled prevalence of FIGO grade 3 was: POLEmut\xa0=\xa019.2%; MMRd\xa0=\xa018.3%; p53abn\xa0=\xa038.1%; NSMP\xa0=\xa014.5%. The pooled prevalence of FIGO stage >I was: POLEmut\xa0=\xa031.6%; MMRd\xa0=\xa042.8%; p53abn\xa0=\xa048.5%; NSMP\xa0=\xa024.6%. Two-, 5- and 10-year PFS was: POLEmut\xa0=\xa0100%, 100%, and 100%; MMRd\xa0=\xa089.1%, 82.2% and 73.3%; p53abn\xa0=\xa061.7%, 50.2% and 39.6%; NSMP\xa0=\xa087.7%, 79.6% and 65.5%. The hazard ratio for disease progression (reference\xa0=\xa0NSMP) was: POLEmut\xa0=\xa0not estimable (no events); MMRd\xa0=\xa00.825 (p\xa0=\xa00.626); p53abn\xa0=\xa02.786 (p\xa0=\xa00.001).\n\n\nCONCLUSION\nThe prognostic value of the TCGA groups was similar between OEC and EEC, despite the differences in the frequency and pathological features of each group.